Vukovic Petar G,Jeremic Aleksandra,Vezmar Milica,Milosavljevic Filip,Pavlovic Zorana Z,Pesic Danilo R,Drakulic-Djordjevic Jelena,Pejuskovic Bojana,Markovic Bojan D,Ingelman-Sundberg Magnus,Miljevic Cedo D,Maric Nadja P,Jukic Marin M (2026) Perceived stress four weeks after initiation of escitalopram monotherapy as a predictor of anxiolytic and antidepressant effects, JOURNAL OF AFFECTIVE DISORDERS, vol. 403, br. , str. - (Article) 

Vukovic Petar G,Jeremic Aleksandra,Vezmar Milica,Milosavljevic Filip,Pavlovic Zorana Z,Pesic Danilo R,Drakulic-Djordjevic Jelena,Pejuskovic Bojana,Markovic Bojan D,Ingelman-Sundberg Magnus,Miljevic Cedo D,Maric Nadja P,Jukic Marin M (2025) Effectiveness and safety of escitalopram treatment personalized based on therapeutic drug monitoring of drug plasma concentration: a prospective cohort study, SCIENTIFIC REPORTS, vol. 15, br. 1, str. - (Article) 

Van Riet Sander,Julien Anais,Atanasov Andrea,Nordling Asa,Ingelman-Sundberg Magnus (2024) The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model, HEPATOLOGY COMMUNICATIONS, vol. 8, br. 3, str. - (Article) 

Van Riet Sander,Julien Anais,Atanasov Andrea,Nordling Asa,Ingelman-Sundberg Magnus (2024) The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model, HEPATOLOGY COMMUNICATIONS, vol. 8, br. 3, str. - (Article) 

Ingelman-Sundberg Magnus,Jukic Marin M,Braten Line Skute,Kringen Marianne Kristiansen,Molden Espen (2024) What is the Current Clinical Impact of the CYP2CTG Haplotype?, CLINICAL PHARMACOLOGY & THERAPEUTICS, vol. 115, br. 2, str. 183-183 (Letter) 

Lenk Hasan Cagin,Lovsletten Smith Robert,O'Connell Kevin S,Jukic Marin M,Kringen Marianne Kristiansen,Andreassen Ole A,Ingelman-Sundberg Magnus,Molden Espen (2023) Impact of NFIB and CYP1A variants on clozapine serum concentration-A retrospective naturalistic cohort study on 526 patients with known smoking habits, CTS-CLINICAL AND TRANSLATIONAL SCIENCE, vol. 16, br. 1, str. 62-72 (Article) 

Jukic Marin M,Milosavljevic Filip,Molden Espen,Ingelman-Sundberg Magnus (2022) Pharmacogenomics in treatment of depression and psychosis: an update, TRENDS IN PHARMACOLOGICAL SCIENCES, vol. 43, br. 12, str. 1055-1069 (Review) 

Braten Line Skute,Ingelman-Sundberg Magnus,Jukic Marin M,Molden Espen,Kringen Marianne Kristiansen (2022) Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population, CTS-CLINICAL AND TRANSLATIONAL SCIENCE, vol. 15, br. 9, str. 2135-2145 (Article) 

Pridgeon Chris S,Bolhuis Dian P,Milosavljevic Filip,Manojlovic Marina,Vegvari Akos,Gaetani Massimiliano,Jukic Marin M,Ingelman-Sundberg Magnus (2022) Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids, CELLS, vol. 11, br. 10, str. - (Article) 

Lenk Hasan Cagin,Kloditz Katharina,Johansson Inger,Smith Robert Lovsletten,Jukic Marin M,Molden Espen,Ingelman-Sundberg Magnus (2022) The Polymorphic Nuclear Factor NFIB Regulates Hepatic CYP2D6 Expression and Influences Risperidone Metabolism in Psychiatric Patients, CLINICAL PHARMACOLOGY & THERAPEUTICS, vol. 111, br. 5, str. 1165-1174 (Article) 

Jukic Marin M,Smith Robert Lovsletten,Molden Espen,Ingelman-Sundberg Magnus (2021) Evaluation of the CYP2D6 Haplotype Activity Scores Based on Metabolic Ratios of 4,700 Patients Treated With Three Different CYP2D6 Substrates, CLINICAL PHARMACOLOGY & THERAPEUTICS, vol. 110, br. 3, str. 750-758 (Article) 

Braten Line Skute,Haslemo Tore,Jukic Marin M,Ivanov Maxim,Ingelman-Sundberg Magnus,Molden Espen,Kringen Marianne Kristiansen (2021) A Novel CYP2C-Haplotype Associated With Ultrarapid Metabolism of Escitalopram, CLINICAL PHARMACOLOGY & THERAPEUTICS, vol. 110, br. 3, str. 786-793 (Article) 

Smith Robert Lovsletten,Tveito Marit,Kylleso Lennart,Jukic Marin M,Ingelman-Sundberg Magnus,Andreassen Ole A,Molden Espen (2021) Rates of complete nonadherence among atypical antipsychotic drugs: A study using blood samples from 13,217 outpatients with psychotic disorders, SCHIZOPHRENIA RESEARCH, vol. 228, br. , str. 590-596 (Article) 

Milosavljevic Filip,Bukvic Nikola,Pavlovic Zorana Z,Miljevic Cedo D,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Leucht Stefan,Jukic Marin M (2021) Association of CYP2C19 and CYP2D6 Poor and Intermediate Metabolizer Status With Antidepressant and Antipsychotic Exposure A Systematic Review and Meta-analysis, JAMA PSYCHIATRY, vol. 78, br. 3, str. 270-280 (Review) 

Milosavljevic Filip,Bukvic Nikola,Pavlovic Zorana Z,Miljevic Cedo D,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Leucht Stefan,Jukic Marin M (2020) Impact of CYP2C19 and CYP2D6 polymorphism on antidepressants and antipsychotics exposure; a meta-analysis, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 40, br. , str. S250-S251 (Meeting Abstract) 

Milosavljevic Filip,Vucic Marija,Manojlovic M,Milosevski T,Batinic Bojan A,Novalen M,Miksys S,Tyndale FR,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M (2020) Reduced cerebellum volume and ataxia-like motoric phenotype in transgenic mouse, carrier of human CYP2C19 gene, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 40, br. , str. S208-S208 (Meeting Abstract) 

Smith Robert Lovsletten,Tveito Marit,Kylleso Lennart,Jukic Marin M,Ingelman-Sundberg Magnus,Andreassen Ole A,Molden Espen (2020) Impact of antipsychotic polypharmacy on nonadherence of oral antipsychotic drugs & ndash; A study based on blood sample analyses from 24,239 patients, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 37, br. , str. 64-69 (Article) 

Van Westrenhen Roos,Aitchison Katherine J,Ingelman-Sundberg Magnus,Jukic Marin M (2020) Pharmacogenomics of Antidepressant and Antipsychotic Treatment: How Far Have We Got and Where Are We Going?, FRONTIERS IN PSYCHIATRY, vol. 11, br. , str. - (Review) 

Braten Line Skute,Haslemo Tore,Jukic Marin M,Ingelman-Sundberg Magnus,Molden Espen,Kringen Marianne Kristiansen (2020) Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients, NEUROPSYCHOPHARMACOLOGY, vol. 45, br. 3, str. 570-576 (Article) 

Milosavljevic Filip,Bukvic Nikola,Pesic Vesna,Molden Espen,Ingelman-Sundberg Magnus,Jukic Marin M (2019) Quantification of antidepressant and antipsychotic exposure increase caused by CYP2C19 and CYP2D6 intermediate and poor metabolizer status by meta-analysis, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 29, br. , str. S533-S534 (Meeting Abstract) 

Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Jukic Marin M (2019) Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 29, br. , str. S399-S400 (Meeting Abstract) 

Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M (2019) Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 29, br. , str. S17-S17 (Meeting Abstract) 

Jukic Marin M,Smith Robert Lovsletten,Haslemo Tore,Molden Espen,Ingelman-Sundberg Magnus (2019) Effect of CYP2D6 genotype on exposure and efficacy of risperidone and aripiprazole: a retrospective, cohort study, LANCET PSYCHIATRY, vol. 6, br. 5, str. 418-426 (Article) 

Milosavljevic Filip,Vucic Marija,Manojlovic M,Asujic N,Batinic Bojan A,Novalen M,Miksys S,Tyndale RF,Ingelman-Sundberg Magnus,Pesic Vesna,Jukic Marin M (2019) Transgenic mouse, carrier of human CYP2C19 gene, as an animal model for hyperdopaminergism-induced hyperkinesia, EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol. 29, br. , str. S672-S673 (Meeting Abstract) 

Haslemo Tore,Eliasson Erik,Jukic Marin M,Ingelman-Sundberg Magnus,Molden Espen (2019) Significantly lower CYP2D6 metabolism measured as the O/N-desmethylvenlafaxine metabolic ratio in carriers of CYP2D6*41 versus CYP2D6*9 or CYP2D6*10: a study on therapeutic drug monitoring data from 1003 genotyped Scandinavian patients, BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, vol. 85, br. 1, str. 194-201 (Article) 

Jukic Marin M,Lauschke Volker M,Saito Takahiro,Hiratsuka Masahiro,Ingelman-Sundberg Magnus (2018) Functional characterization of CYP2D7 gene variants, PHARMACOGENOMICS, vol. 19, br. 12, str. 931-936 (Article) 

Jukic Marin M,Haslemo Tore,Molden Espen,Ingelman-Sundberg Magnus (2018) Impact of CYP2C19 Genotype on Escitalopram Exposure and Therapeutic Failure: A Retrospective Study Based on 2,087 Patients, AMERICAN JOURNAL OF PSYCHIATRY, vol. 175, br. 5, str. 463-470 (Article) 

Aklillu Eleni,Djordjevic Natasa D,Carrillo Juan Antonio,Makonnen Eyasu,Bertilsson Leif,Ingelman-Sundberg Magnus (2014) High CYP2A6 Enzyme Activity as Measured by a Caffeine Test and Unique Distribution of CYP2A6 Variant Alleles in Ethiopian Population, OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, vol. 18, br. 7, str. 446-453 (Article)